- Student Records
Programme & Unit Catalogues


BB50245: Advances in molecular medicine

Follow this link for further information on academic years Academic Year: 2019/0
Further information on owning departmentsOwning Department/School: Department of Biology & Biochemistry
Further information on credits Credits: 20      [equivalent to 40 CATS credits]
Further information on notional study hours Notional Study Hours: 400
Further information on unit levels Level: Masters UG & PG (FHEQ level 7)
Further information on teaching periods Period:
Academic Year
Further information on unit assessment Assessment Summary: CW 50%, EX-TH 40%, OT 10%*
Further information on unit assessment Assessment Detail:
  • Online Tests on Core Knowledge* (OT 10%)
  • Research Paper Seminar Presentation* (CW 20%)
  • Literature Review (2000-3000 words)* (CW 30%)
  • Open Book Examintation of 24 hours duration* (EX-TH 40%)

*Assessment updated due to Covid-19 disruptions
Further information on supplementary assessment Supplementary Assessment:
Like-for-like reassessment (where allowed by programme regulations)
Further information on requisites Requisites:
Further information on descriptions Description: Aims:
The unit is aimed at synthesising and advancing our knowledge of how molecular, cellular and genetic / epigenetic processes regulate human health and disease.

Learning Outcomes:
By the end of this unit you will be able to:
* Apply your understanding of your core molecular medicine knowledge drawing on concepts in the molecular and cellular basis of disease
* Critically evaluate and communicate the findings of a cutting-edge molecular medicine research publication through a formal presentation
* Critically evaluate, synthesise and summarise the findings of a variety of cutting-edge molecular medicine research publications through a written literature review
* Demonstrate an integrative and evaluative approach to addressing some of the challenges and opportunities in treating human diseases.

Content:
This unit is aimed at synthesising and advancing our knowledge of how molecular, cellular and genetic / epigenetic processes regulate human health and disease. Topics will include:
* molecular genetics/epigenetics of cancer, diabetes, stem cell reprogramming, medical neuroscience, immunology and epidemiology of infections.
* Molecular approaches used to develop interventions (genomics for vaccine and chemotherapeutic target identification, Next Generation Sequencing, epidemiology and prediction, regenerative medicine, personalised medicine).
Further information on programme availabilityProgramme availability:

BB50245 is a Designated Essential Unit on the following programmes:

Department of Biology & Biochemistry
  • RSBB-AFM50 : Integrated PhD Molecular Biosciences (Medical Biosciences)
  • TSBB-AFM50 : MSc Molecular Biosciences (Medical Biosciences)

Notes: